As of November 2024, Cynata Therapeutics has a market cap of $18.65M. This makes Cynata Therapeutics the world's 29351th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $17.18M | 40.00% |
2023 | $12.27M | -58.33% |
2022 | $29.45M | -44.95% |
2021 | $53.50M | -20.44% |
2020 | $67.24M | -34.13% |
2019 | $102.09M | -20.00% |
2018 | $127.61M | 109.68% |
2017 | $60.86M | -15.07% |
2016 | $71.66M | 105.63% |
2015 | $34.85M | 4.41% |
2014 | $33.37M | -32.00% |
2013 | $49.08M | 56.25% |
2012 | $31.41M | 166.67% |
2011 | $11.78M | -92.31% |
2010 | $153.13M | -40.00% |
2009 | $255.22M | 160.00% |
2008 | $98.16M | -77.27% |
2007 | $431.90M | - |